Bastiaan Privé studied medicine at the Vrije Universiteit in Amsterdam. He finished his study in 2016. Subsequently, he worked for 2 years as a resident in Urology. During that period he developed a strong interest in prostate cancer. In 2018 he started his PhD project at the department Radiology and Nuclear Medicine. He will work on several clinical studies concerning Lu-177 PSMA treatment. He will be supervised by Sandra Heskamp, James Nagarajah and Martin Gotthardt.